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Abstract
Purpose of review Human pluripotent stem cells (hPSCs) are
anchorage-dependent cells that can be cultured on a variety of
matrices and express integrins and the machinery for integrin
signaling. Until recently, there has been limited understanding
of exactly how integrin signaling regulates pluripotent stem
cell (PSC) behavior. This review summarizes our knowledge
of how integrins and focal adhesion kinase (FAK) regulate
different aspects of hPSC biology.
Recent findings The latest research suggests that mouse and
human embryonic stem cells utilize similar integrin signaling
players but with different biological outcomes, reflecting the
known developmental difference in their pluripotent status.
Notably, attachment cues via FAK signaling are crucial for
hPSCs survival and pluripotency maintenance. FAK may be
found cortically but also in the nucleus of hPSCs intersecting
core pluripotency networks.
Summary Integrins and FAK have been consigned to the con-
ventional role of cell adhesion receptor systems in PSCs. This
review highlights data indicating that they are firmly integrat-
ed in pluripotency circuits, with implications for both research
PSC culture and scale up and use in clinical applications.
Keywords Pluripotent stem cells . Human embryonic stem
cells .Stemcellniche .FAK . Integrin signaling .Pluripotency
networks
Introduction
Human embryonic stem cells (hESCs) derived from cells of the
inner cell mass of the blastocyst and induced pluripotent stem
cells (iPSCs) reprogrammed from somatic cells to an ESC-like
state have attractedmuch interest in recent years because of their
promise in understanding early human development, formodel-
ingmonogenic diseases, and for producing cell-based therapies.
In order to utilize these pluripotent stem cells (PSCs) to their full
potential, we need to be able to culture them stablywithminimal
death or differentiation, retaining their plasticity and responsive-
ness together with the ability to undergo repeated cell division
(self-renewal).Thus, thedevelopmentofappropriateculturecon-
ditions (including those suitable for clinical use) has generated a
thriving industry.
Although the importance of cell-cell interactions for stable
hESC growth is well established, the role of cell-substrate
interactions is not fully understood. There is documented ev-
idence of a role for integrins [1, 2], and knowledge of the
integrin complement has often been exploited, matching them
to more favorable single extracellular matrix (ECM) sub-
strates for culture [2–5]. However, the machinery and signal-
ing pathways linking these interactions to the pluripotent state
are still not entirely clear. In this review, we summarize find-
ings relating to the stable substrate growth of PSCs and the
role of integrins and focal adhesion kinase (FAK) in the trans-
duction of signals from the substrate.
Into the Pluripotent Stem Cell Niche
In vivo, adult stem cells reside as quiescent cells in specific
locations of many human organs referred to as Bniches^ [6]
which offer a protected and finely controlled environment for
their long-term maintenance [7]. Although the pluripotent
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stem cell niche in vivo is only a transient developmental stage
[8], in vitro, pluripotent stem cells can grow indefinitely under
controlled culture conditions, and it has been found that
hESCsmay also produce their own niche of surrounding feed-
er cells [9, 10] and ECM [4].
A specialized niche for ESCs requires a set of extracellular
cues, both chemical and physical, that sustains the core-
circuitry linked to proliferation, survival, and pluripotency.
While the roles of soluble factors such as FGF and TGFβ
family growth factors and, to a certain extent, cell-cell inter-
action have been extensively studied in controlling stem cell
behavior, the unique contribution of ECM-dependent path-
ways has been less investigated.
In the context of the stem cell niche, the ECM plays three
main roles: (i) cell anchorage, (ii) growth factor and morpho-
gen reserve, and (iii) a mediator of biomechanical stiffness
including through modification of its density and elasticity
[11]. In a regular stem cell niche, these three roles are all
present and linked making the ECM regulation of stem cells
of considerable importance. ECM components have been
found to bind growth factors and morphogens with high af-
finity, thus creating local gradients of concentrated factors
adjacent to their cell surface receptors [12]. Other ECM do-
mains bind to predominantly integrin receptors. By these
means, the ECM acts as a scaffold that simultaneously and
spatially concentrates integrins, growth factors, and growth
factor receptors, thus activating common downstream path-
ways known to crosstalk and activate one another [12].
Over the years, several groups have developedmethods that
recreate an artificial pluripotent stemcell niche.A turning point
was achieved with the direct culturing of hESCs on purified
ECM molecules, such as vitronectin, fibronectin, and laminin
known to be secreted by bothMEFs and hESCs [2–4, 13–18].
Integrin Receptors in ES Cells
Integrins are heterodimers formed by combinations of 18α
subunits and 8β subunits, giving a total of 24 glycoproteins
with distinct binding preferences, functions, and knockout
phenotypes [19]. Structurally, all integrins are composed of a
large extracellular domain, a single transmembrane domain,
and a short cytoplasmic tail [20]. The cohort of integrins
expressed by a cell determines the type of ECM-cell interac-
tion, which can dramatically change cell behavior.
Murine ESC Integrins
β1-integrin has been associated particularly with stemness in
adult and embryonic stem cells [21]. It is present throughout
preimplantation embryonic development [22], and β1 integrin-
null mice show survival, proliferation, and migration defects of
early embryonic tissues developing from the inner cellmass [23]
and die after implantation [24]. However, ECM components
used for culturing undifferentiated mESCs (e.g., gelatin, or
poly-D-lysine)donotallactivate integrins,andithasbeenargued
that electrostatic interaction is more important than integrin-
matrix binding [25], but it is clear that integrin-substrate interac-
tionsplaya role. Indeed, byusing3Dhydrogels carrying integrin
selective peptides (e.g., RGD), others have shown a direct corre-
lation between activation of 4 mESC integrins (α5β1, αvβ1,
α6β1, and α9β1) and an increase in pluripotency markers
[26]. Integrinα5β1 is considered the fibronectin receptor, bind-
ing fibronectin via the RGD peptide [27]. Hayashi et al. [25]
showed that growing mESCs on integrin-activating substrates,
suchas fibronectinorvitronectin,negativelycorrelatedwithboth
their proliferationandself-renewal.This is supportedby the find-
ing that integrinactivation inmESCs increasesERK[25],known
to inhibit the self-renewal of these cells [28]. Moreover, others
showed that only laminin-511, but not other laminin isoforms,
supportsmESCsself-renewal,viamainlyα6-andαVβ1integrin
engagement [29]. These combined data indicate that mESCs do
not require activation of integrin signaling for their self-renewal.
On the contrary, integrin activation generally induces differenti-
ation ofmESCs [25] andnegatively regulates pluripotency (with
theapparentexceptionofα6-andαVβ1integrinonlaminin511),
which is sustainedpredominantly by soluble factors and through
attachments to adjacent cells.
Human ESC Integrins
Under current culture regimes, hESCs are maintained in an
undifferentiated state in the absence of feeder cells by the use
of single ECM substrates. Because many ECM molecules
activate a particular subset of integrins, even on single sub-
strates several integrins could be engaged, although certain
heterodimers will dominate.
AlthoughhESCs tend to express a series of integrins [2, 4, 5], a
restricted number has been found to be functional [30]. Indeed,
hESCs on Matrigel (a laminin-rich ECMmixture) have been re-
ported to adherebyαVβ3,α6β1, andα2β1, assessedby interfer-
ingwith direct attachment using blocking antibodies and peptides
[30].However,singleECMsubstratesratherthanmixedsubstrates
are preferable to assess integrin function.HESCsbind to fibronec-
tin selectively via its established preferential integrin receptor,
α5β1 [2, 3] while on vitronectin,αVβ5 is activated [2]. HiPSCs
similarly express integrin subunits, particularly α5, α6, αv, β1,
andβ5, andattachandproliferateonMatrigelviaβ1 integrinsand
onvitronectinusingαVβ5andβ1integrins[31].Finally,againβ1
integrin, in combination with α6, mediates the strong binding of
hESCs and hiPSCS to recombinant laminin-511 [2, 18].
Overall, the repertoire of integrins expressed by hESCs and
hiPSCs on selective ECM components has been shown to be
restricted and substrate-biased.
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Integrin Signaling: a Glance at the Focal Adhesion
Kinase Pathway
In many cells, small focal complexes at the leading edge of the
cellsmediate the firstattachment to theECM.Subsequently, these
complexes stabilize, generating focal adhesions (FA) in parallel
to the retraction of the lamellipodium. FAprovide strong binding
to the ECM and the cytoplasmic recruitment of a whole
network of interacting proteins [32•] including actin fibrils [33].
Following thebindingof talinandkindlin to theβ-integrin tail
(and itsactivationbyligandbinding), the firstECM-cytoskeleton
link is established through these structural connecting proteins
[34].Because activation promotes the clustering of the integrins,
multiple talin-mediatedconnections toactin fiberscreatea robust
ECM-cytoskeletoninteractionandprovideastartingpoint for the
assembly of the adhesome.
One of the first signaling proteins recruited at the adhesome is
focal adhesion kinase (FAK), a non-receptor tyrosine kinase that
binds talin and paxillin via its C-terminal focal adhesion-targeting
(FAT) domain [35]. FAK is a crucial FA protein that intersects
many pathways and triggers the cellular response to ECM by
acting as a signaling integrator. It contains three main domains
and two linkers. The C-terminal FAT domain [36] is responsible
for localization of FAK to focal contacts and contains hydropho-
bic binding sites for paxillin. One of the tyrosine residues of FAK
that is in the FAT domain, Tyr 925, when phosphorylated stabi-
lizes a conformation that allows binding of the SH2 domain of
Grb2 [37]. The tyrosine kinase domain is bilobed and contains an
ATP binding site responsible for kinase activity. In order to be
fully activated, Tyr576 and Tyr577 within the activation loop
need to be phosphorylated by Src [38]. The N-terminal band
4.1 Ezrin Radixin Moesin (FERM) domain is trilobed as for
many other FERM domains [39] and responsible for nuclear
localization, auto inhibition of FAK kinase activity, and facilita-
tion of survival pathways [36]. The linker region between
the FERM and kinase domain contains the autophosphorylation
site in Tyr397 (Y397). Autophosphorylation at Y397 is the first
event that activates FAK after recruitment to focal contacts, cre-
ating an SH2-binding site for Src and PI3K [40]. It also contains
proline-rich BPxxP^ motifs that are recognized by SH3-binding
proteins like Src [41]. The linker region between the kinase and
FATdomains also contains two SH3-binding sites for scaffolding
proteins like p130Cas [42].
Following integrin activation, FAK is autophosphorylated
at Y397 permitting a low level of kinase activity and creating
an SH2 binding site for proteins like the p85 regulatory sub-
unit of PI3K [43] and Src-family protein tyrosine kinases,
mainly Src itself [37, 40]. The FAK/Src complex allows phos-
phorylation of the activating loop of the kinase domain by Src,
leading to full FAK activity [37]. Active FAK in turn phos-
phorylates Src, which propagates the signal and promotes the
aggregation of adhesome proteins around FAK [44]. For ex-
ample, after phosphorylation on Tyr 925 by Src, the Grb2-
SOS complex binds FAK, generating crosstalk between
ECM and growth factor signals [40]. Grb2 transduces the
signal to RAS/Raf/MEK and finally ERK, while Src phos-
phorylates p130Cas, associated with FAK, and upstream of
JNK: both cascades converge into cell cycle progression
[40]. Notably, FAK activation downstream of α5β1-integrin
can co-operate with signals from the FGF-2 receptor for the
activation of PI3K and subsequently activation of both the Akt
and the RAS/MAPK cascade [45]. FAK also plays a pivotal
role in the spreading, protrusion, and invasion of many but not
all cells [46–48]. Overall, integrin activation of the FAK-Src
complex induces signaling cascades connected with survival,
motility, and cell cycle progression.
Life and Death by FAK
One of the pivotal roles of FAK in the cell is the control of
survival. In epithelial cells, loss of attachment to the ECM
triggers a special form of apoptosis, named anoikis [49].
Anoikis is executed by the mitochondrion downstream of an
integrin signaling cascade [50]. Indeed, it is rescued if the cells
are re-plated on fibronectin or on culture dishes coated with
β1-integrin antibodies [51]. Moreover, constitutive expres-
sion of FAK protects the cells from anoikis [52], while
blocking the interaction of FAK with the cytoplasmic tail of
β1-integrin leads to high levels of anoikis [53].
The cellular control of survival is principally mediated by
PI3K [54, 55•], a survival pathway confirmed in mESC [56,
57], hESCs [58, 59], and hiPSCs [60]. In mESCs, PI3K acts to
inhibit both MAPK/ERK required for differentiation and
GSK3β, the latter leading to upregulation of Tbx3 and Nanog
[55•, 61, 62]. Blocking FAKor inhibiting Src reduces the activa-
tionof thep85 subunit ofPI3Kaswell as phosphorylationofAkt
at Ser473, and promotes apoptosis of fibroblasts. Enforced acti-
vation of β1-integrin or overexpression of PI3K p110 catalytic
subunit rescues cells from apoptosis caused by dominant nega-
tive FAK, thus showing that FAK acts upstream of PI3K/Akt in
the suppression of apoptosis byβ1-integrin [63]. The tail region
of integrinsβ1 andβ3 can bind the linked integrin kinase (ILK),
whichinturnappears toactivateAkt[64].OverexpressionofILK
can also prevent anoikis [65] in some settings. However, ILK
does not have classic catalytic residues and it is considered to
be a pseudokinase; therefore any role in regulating Akt, or in
formation of cell-ECM contacts, is likely due to ILK interaction
with molecular partners Pinch and Parvin (IPP complex) [66].
So,what pathways lie downstreamofAkt to prevent anoikis?
Activated Akt induces the transcription factor NFkB, which up
regulates pro-survival Bcl-2 proteins (Bcl-2 and Bclxl) [67].
Overexpression of Bcl2 in cells without integrin α5β1 blocks
anoikis [68]. Interestingly, the translocation of NFkB to the nu-
cleus, also mediated by ERK (in the MAPK cascade), seems to
require integrin engagement [69].
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Another target of Akt is MDM2, involved in the proteasome-
mediated degradation of p53. The p53 protein is an effector of
anoikis, and this process is regulated byFAK: in its absence, there
is an increasedp53-dependent apoptosis [70].Moreover, Ilic et al.
showed that mutation in the DNA-binding region of p53 did not
interfere with the induction of apoptosis, instead p53 protein acts
directly on the caspase cascade in its execution phase [70].
Investigation of the FERM domain of FAK has revealed
new roles for FAK in the nucleus. The FERM domain corre-
lates with nuclear localization of FAK [71], and Goluboskaya
et al. [72, 73] showed that it interacts directly with the N-
terminal transactivation domain of p53 to inhibit its activity.
Under reduced cell adhesion, FAK leaves FAs and localizes in
the nucleus to act in a kinase-independent manner facilitating
survival [74]. In particular, FAK’s FERM domain functions as
a scaffold for MDM2-dependent p53 ubiquitination, thus in-
creasing p53 turnover as a survival strategy [74].
Overall, although the general characteristics of FAK survival-
signaling involve similarmolecules in different cells, it ismore likely
that preferred pathways are activated in a cell type-specific manner.
Integrin Signaling in ES Cells
Currently, detailed reports of integrin/FAK signaling mecha-
nisms operating in ESCs are scarce compared to the literature
on adult cell types. However, several studies have mapped the
activity of some key downstream signaling players following
integrin engagement in ESCs, paving the way to our under-
standing of how ESC integrin signaling responds to ECM
cues in the context of a pluripotent niche.
Integrin-activating substrates, such as vitronectin, laminin,
and fibronectin, are effective for maintaining self-renewal of un-
differentiated hESCs under fully defined conditions [2, 3, 18] as
described above. By contrast, integrin engagement and integrin
signaling activation in mESCs induce the opposite effect and
trigger differentiation [25, 75•]. Indeed, culturing mESCs on fi-
bronectin or laminin precipitates differentiation via activation of
FAK and Akt, while collagen support pluripotency [25]. In line
with these findings, it was shown that α6β1 and α3β1 integrin
engagement with laminin facilitates mESC differentiation to-
wards an epithelial lineage [75•]. Activated α6-integrin interacts
with the adaptor protein CD151 inducing α6β1 internalization,
in turn eliciting a FAK/Akt cascade that leads to phosphorylation
of Erk and ultimately cell fate specification [75•]. Furthermore,
the role of integrin signaling inmESC fate has been addressed by
adding ECM ligands to magnetic beads [76]. MESCs incubated
with RGD, fibronectin, or laminin-coated beads decreased Oct-4
expression while beads coated with the cell-cell adhesion recep-
tor E-cadherin did not decrease Oct-4 [76]. Thus, pluripotency in
mESC and hESC seems similarly affected by cell-cell contact
cues but not integrin engagement, although the bead application
does not provide the same vectorial substrate presentation as a
culture surface. In addition to stimulating differentiation, integrin
engagement in mESCs plays a role in cell cycle regulation [77].
Addition of fibronectin to the medium of mESCs cultured on
gelatin induced a FAK/Src/Calvelolin/RhoA/PI3K/Erk1/2 path-
way that supports proliferation [77].
In hESCs, however, even under different culture conditions,
activation of similar integrin signaling components does not halt
but rather supports pluripotency, self-renewal, and survival [5,
78, 79, 80••]. The evidence available suggests that mESCs differ
from hESCs not just in their response to soluble morphogens,
like LIF and BMPs, but also in the outcome of the integrin sig-
naling responses downstream of attachment to the ECM
(Table 1).
There is a general agreement that adherence to ECM sub-
strates that engage integrins leads to activation of both FAK
and AKT in hESCs [5, 78, 79, 80••]. Not surprisingly, the mod-
ulation of the integrin signaling seems to vary depending on the
ECM and culture conditions employed in these studies. For ex-
ample, FAK, AKT, and ERK were more strongly activated in
hESCs grown on recombinant E8 fragments of laminin than on
vitronectin or fibronectin, which however all supported their
phosphorylation [78, 79, 80••]. However, one report concluded
that integrin/FAK signaling is only activated during differentia-
tion of hESCs, while nuclear FAK maintains the pluripotency
circuits [81••]. An explanation for this discrepancy can be found
in the dynamic of FA formation. Focal adhesions are not present
in pluripotent stem cells [3, 80••]—rather, integrin and associated
molecules are found in puncta around the cell surface. Antibody
activation of β1-integrin caused FAK to be prominently at the
membrane, suggestive of co-localization with focal adhesions,
while pluripotency-associated marker OCT4 decreased [81••].
Thus, hESCs already express β1-integrins and key focal adhe-
sion components, such as paxillin, but these only assemble into
focal adhesions upon differentiation [80••]. Therefore, integrin/
FAK signaling seems non-canonical in hESCs, only to switch
into its typical Badult^ signaling following loss of pluripotency.
Such singular and dynamic integrin signaling in hESCs is
highlighted by studying the behavior of integrin/FAK sig-
naling in cells grown under both self-renewing and differ-
entiating conditions.
Multiple Roles for FAK in Human Pluripotent Stem
Cells
Although we are only starting to dissect FAK’s regulation of
hESC behavior, initial evidence points to important and varied
roles in the context of pluripotent stem cells.
Afrikanova et al. [82] have looked at the role of FAK dur-
ing derivation of β–cells from hESCs. They showed that in-
hibition of FAK or the FAK/Src complex improved endocrine
specification, as well as inhibiting progenitor proliferation, by
suppressing Smad2/3 [82]. These findings, in the context of
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differentiation-inducing culture conditions, demonstrate that
FAK supports Smad2/3 signaling, pivotal in regulating the
balance between pluripotency and differentiation [59]. This
may result from FAK signaling crosstalk with the TGF-β
cascade [82]. That integrin signaling poses a block towards
differentiation of hESCs was also indicated by a report showing
that inhibition of ILK, but not FAK, during endoderm differen-
tiation reduced FAK and AKT phosphorylation while increasing
SOX17-positive cells [79]. It is worth noting that FAK Y397,
upstream of the PI3K/AKTcascade, was dephosphorylated after
ILK inhibition, making it difficult to exclude its involvement in
the activation of AKT. Moreover, these experiments were per-
formed on cells grown onMatrigel, so activation of receptors for
a number of ligands may affect downstream FAK/ILK/AKT
transduction.
It is important to keep in mind that hESCs subject to varied
differentiation protocols will interact with the ECM in a multi-
tude of ways given their dynamic transitioning cell state and
according to the specific cocktail of extrinsic factors. Indeed,
Table 1 Current knowledge of integrin signaling in mouse versus
human ESCs
Features of integrin signaling mESca hESca
Present in focal adhesions ✕ ✕
Integrin-activating substrates maintain pluripotency ✕(✓) ✓
Integrin signals transduced through FAK ✓ ✓
Integrins transduced through PI3K/ Akt ✓ ✓
Integrins transduced through ILK ✓ ✓
Integrins transduced through ERK ✓ ✓
Integrin engagement supports proliferation ✓ ✓
Integrin/FAK activation inhibit anoikis N/a ✓
Integrin/FAK activation inhibit hypercontractility N/a ✓
Nuclear FAK N/a ✓
✓ yes, ✕ no, N/a not available
a Referring to self-renewing undifferentiated culture conditions
Fig. 1 Diagram illustrating FAK
signaling in hESCs. Stable ECM/
integrin interaction induces
activation of FAK,
phosphorylated at Y397, at the
cell surface, initiating the
transduction of attachment cues to
the cell. In turn, FAK Y397
activates the PI3K survival
cascade, leading to
phosphorylation of AKT and its
downstream target MDM2. This
allows MDM2 to continuously
ubiquitinate p53 targeting it for
proteosome degradation and
maintaining low levels so that it
cannot induce differentiation or
apoptosis. In addition, FAK is
localized in the nucleus where it
binds pluripotency factors but can
also exert its scaffolding roles in
support of MDM2
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research has focused on how to better exploit integrin signaling
during diverse differentiation protocols, particularly relevant
for clinical applications [83].
However, investigating FAK signaling in undifferentiated
hESCs grown on a single ECM component, fibronectin, con-
firmed that FAK transduces integrin engagement through AKT
to keep the balance of hESC phenotype towards self-renewal
[80••]. Indeed, inhibition of either integrins or FAK is enough
tosuppressAKTandincreasep53,ultimatelydrivingthecellsout
of the undifferentiated state, as demonstrated by downregulation
of OCT4 and NANOG and increase in differentiation markers
[80••]. The fact that the inhibition of FAK alone induced the exit
from pluripotency in cells kept in self-renewing media suggests
how unique and profound the contribution of ECM cues to the
maintenance of hESCs is.
However, akeyfunctionofFAKinhESCs isconsistentwith its
well-known survival role in the cell: FAK transduces integrin en-
gagement to a PI3K/AKT/MDM2/p53 cascade that suppresses a
caspase-dependent anoikis (80••; Fig. 1). In addition, FAK sup-
ports adhesion to the ECM and suppresses hypercontractility
[80••], which is in accord with FAK’s known role in
mechanotransduction [46, 48].
As we have seen, FAK not only works as a kinase in the
adhesome, it also acts as a scaffold in the nucleus [74].
Interestingly, inundifferentiated hESCs,where focal adhesions
are not formedbut FAKsignaling is active [80••], FAK is found
at the membrane, in the cytosol, and dephosphorylated FAK is
also relatively high in the nucleus [80••, 81••]. Moreover, after
kinase inhibition, the total pool of FAKdecreased [80••], while
in adult cell types, where FAK is not normally nuclear, it accu-
mulates in thenucleus toscaffold the turnoverofp53byMDM2
and supports survival under stress [74].Thesedata suggest that,
in hESCs, nuclear FAK likely already supports turnover of p53
in standard conditions, but when detachment or loss of integrin
signaling issensed, itquicklydecreases,allowingsustainedp53
activity and progress to anoikis or differentiation [80••].
Overall, these findings suggest that hESCs utilize integrin/
FAKsignaling innon-canonicalways thatweare just starting to
uncover. A fascinating example of this comes from the fact that
a nuclear poolofFAKinhESCsmight playother roles connect-
ednotwithsurvival,butwithpluripotency, similar to findings in
cancer.Cancercells sharemanycharacteristicswithESCs, such
as the expression of the self-renewal factorNanog [84]. In rela-
tion toFAK, itwas shown thatNanogbinds to theFAKpromot-
er and FAK binds and phosphorylates Nanog in the nucleus
[84]. Not only is FAK in the nucleus of stable hESCs [80••,
81••] but it was shown to co-immunoprecipitate with SOX2
and OCT4 but not NANOG [81••], and our unpublished pull-
down experiments confirm this finding. This suggests that the
intersection of FAK signaling with the pluripotency circuits
may bemore complex than previously assumed (Fig. 1).
Evidence to date indicates that the ECM significantly con-
trols hESC life, death, and fate via integrin/FAK signaling for
survival, adhesion, and supporting pluripotency signaling net-
works by means of canonical and non-canonical mechanisms
that are worth further investigation.
Conclusions
Both mESCs and hESCs rely on FAK and integrin signaling as
part of the repertoire of signals guiding and expediting their
differentiation. FAK has multiple roles in ESCs, such as in sur-
vival, proliferation, anchorage, contractility, and support or inhi-
bition of self-renewal. The available literature points to different
roles for integrins and FAK between hESCs and mESCs, possi-
bly because the former are at a primed state ready to differentiate
on induction and this may be a switch point triggering hESC
dependence on FAK for maintenance as healthy pluripotent
and dividing stem cells. Moreover, it is possible that integrin/
FAK interactionwith the cytoskeleton internally and via crosstalk
with growth factor and other exogenous signaling pathways con-
tribute to a cell state receptive to following different lineage
pathways as instructed by other dominant factors. The evidence
of FAK in the nucleus of hESCs is fascinating and would need
further work to determine if similar pathways are operating to
those shown in cancer cells.
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